Sub-groups | Triglyceride group (mg/dl) | Per 1 mmol/L TG | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
<90 | 90-146 | 150-199 | ≥200 | |||||||
N* | RR (95% CI) | N* | RR† | N* | RR (95% CI) | N* | RR (95% CI) | N* | RR (95% CI) | |
Age (year) | ||||||||||
<50 | 3 | 0.88 (0.78, 1.00) | 5 | 1.00 | 5 | 1.14 (1.05, 1.24) | 5 | 1.20 (0.99, 1.46) | 8 | 1.13 (1.05, 1.21) |
≥50 | 9 | 0.97 (0.85, 1.11) | 9 | 1.00 | 9 | 1.07 (0.97, 1.18) | 3 | 1.20 (0.97, 1.48) | 14 | 1.12 (1.07, 1.17) |
P value | 0.311 | 0.329 | 0.982 | 0.845 | ||||||
Gender | ||||||||||
Male | 8 | 0.95 (0.84, 1.09) | 9 | 1 | 9 | 1.12 (1.02, 1.22) | 5 | 1.23 (1.09, 1.38) | 14 | 1.09 (1.04, 1.13) |
Female | 6 | 0.91 (0.84, 0.99) | 6 | 1 | 6 | 1.17 (0.99, 1.39) | 2 | 1.01 (0.59, 1.74) | 10 | 1.24 (1.15, 1.32) |
Mixed | 3 | 1.00 (0.85, 1.17) | 4 | 1 | 4 | 1.11 (1.01, 1.21) | 3 | 1.17 (1.01, 1.35) | 6 | 1.08 (1.03, 1.13) |
P value | 0.577 | 0.621 | 0.491 | 0.001 | ||||||
Follow-up (year) | ||||||||||
<15 | 6 | 0.89 (0.84, 0.94) | 7 | 1.00 | 7 | 1.11 (0.97, 1.26) | 4 | 1.26 (1.06, 1.51) | 14 | 1.05 (1.02, 1.07) |
≥15 | 6 | 0.94 (0.79, 1.11) | 7 | 1.00 | 7 | 1.09 (1.02, 1.16) | 4 | 1.15 (0.93, 1.41) | 8 | 1.22 (1.16, 1.29) |
P value | 0.569 | 0.773 | 0.490 | 0.000 | ||||||
Fast status | ||||||||||
Fast | 8 | 1.01 (0.86, 1.20) | 11 | 1.00 | 11 | 1.08 (0.98, 1.18) | 5 | 1.27 (1.09, 1.48) | 15 | 1.12 (1.06, 1.19) |
Nonfast | 2 | 0.91 (0.86, 0.98) | 3 | 1.00 | 3 | 1.14 (1.04, 1.24) | 3 | 1.11 (0.88, 1.40) | 6 | 1.11 (1.03, 1.19) |
Others§ | 2 | 0.79 (0.63, 0.99) | 2 | 1.00 | 2 | 1.11 (0.89, 1.38) | 0 | - | 1 | 1.19 (1.09, 1.30) |
P value | 0.258 | 0.381 | 0.335 | 0.740 | ||||||
Geographic location | ||||||||||
Europe/America | 10 | 0.96 (0.87, 1.06) | 11 | 1.00 | 11 | 1.09 (1.00,1.19) | 6 | 1.19 (0.98, 1.45) | 16 | 1.12 (1.06, 1.17) |
Asia-Pacific | 2 | 0.81 (0.59, 1.11) | 3 | 1.00 | 3 | 1.12 (1.02, 1.23) | 2 | 1.22 (1.08, 1.39) | 6 | 1.13 (1.08, 1.20) |
P value | 0.302 | 0.633 | 0.813 | 0.640 | ||||||
Quality score | ||||||||||
<7 | 5 | 0.90 (0.86, 0.94) | 7 | 1.00 | 7 | 1.15 (1.08, 1.24) | 4 | 1.22 (1.07, 1.40) | 10 | 1.13 (1.08, 1.18) |
7-9 | 7 | 0.95 (0.77, 1.17) | 7 | 1.00 | 7 | 1.03 (0.91, 1.17) | 4 | 1.19 (0.91, 1.57) | 12 | 1.11 (1.05, 1.18) |
P value | 0.594 | 0.116 | 0.869 | 0.707 | ||||||
Sample size | ||||||||||
<4000 | 7 | 0.97 (0.75, 1.25) | 7 | 1.00 | 7 | 1.03 (0.92, 1.15) | 4 | 1.22 (1.03, 1.45) | 13 | 1.14 (1.07, 1.22) |
≥4000 | 5 | 0.92 (0.86, 0.96) | 7 | 1.00 | 7 | 1.14 (1.04, 1.24) | 4 | 1.18 (0.95, 1.45) | 9 | 1.09 (1.04, 1.14) |
P value | 0.729 | 0.155 | 0.778 | 0.190 | ||||||
Free of CVDs at baseline | ||||||||||
Yes | 5 | 0.94 (0.85, 1.03) | 6 | 1.00 | 6 | 1.07 (0.99, 1.16) | 5 | 1.24 (0.99, 1.56) | 13 | 1.10 (1.04, 1.16) |
No | 7 | 0.97 (0.80, 1.16) | 8 | 1.00 | 8 | 1.10 (0.99, 1.23) | 3 | 1.14 (1.00, 1.30) | 9 | 1.13 (1.07, 1.20) |
P value | 0.711 | 0.663 | 0.519 | 0.480 | ||||||
Adjustment | ||||||||||
Minimally | 9 | 0.86 (0.72, 1.03) | 10 | 1.00 | 10 | 1.14 (0.99, 1.30) | 7 | 1.38 (1.13, 1.67) | 8 | 1.12 (1.01, 1.24) |
Maximally | 9 | 0.94 (0.80, 1.11) | 10 | 1.00 | 10 | 1.07 (0.99, 1.17) | 7 | 1.18 (1.01, 1.38) | 8 | 1.07 (1.01, 1.13) |
P value | 0.466 | 0.487 | 0.222 | 0.432 | ||||||
Adjustment for TC | ||||||||||
Yes | 5 | 0.84 (0.7, 0.99) | 5 | 1.00 | 5 | 1.03 (0.93, 1.14) | 2 | 1.10 (0.88, 1.38) | 11 | 1.10 (1.05, 1.15) |
No | 7 | 1.00 (0.89, 1.12) | 9 | 1.00 | 9 | 1.12 (1.02, 1.24) | 8 | 1.27 (1.16, 1.40) | 11 | 1.14 (1.07, 1.21) |
P value | 0.103 | 0.225 | 0.239 | 0.382 | ||||||
Adjustment for HDL | ||||||||||
Yes | 2 | 1.03 (0.93, 1.14) | 2 | 1.00 | 2 | 1.02 (0.89, 1.17) | 1 | 1.35 (1.09, 1.66) | 4 | 1.07 (1.04, 1.11) |
No | 10 | 0.92 (0.82, 1.02) | 12 | 1.00 | 12 | 1.11 (1.03, 1.20) | 8 | 1.14 (0.93, 1.39) | 18 | 1.12 (1.07, 1.17) |
P value | 0.115 | 0.296 | 0.250 | 0.132 |